President Cyril Ramaphosa has reaffirmed South Africa's commitment to universal healthcare through the National Health Insurance scheme, even as legal challenges mount and cost estimates soar into the hundreds of billions.
"The NHI is a commitment we are not prepared to move away from," Ramaphosa told parliament this week, the third time he has repeated this assertion in under a month. The declaration comes despite the government agreeing to suspend proclamation of the NHI Act pending Constitutional Court hearings scheduled for May 2026.
The scheme faces fierce resistance. Analysts estimate annual costs between R250 billion and R1.3 trillion, figures the Department of Health has rejected without providing alternatives. The National Treasury has yet to implement any proposed funding mechanisms, raising questions about the government's capacity to deliver on its promise.
Yet implementation work continues. Over the past 15 months, the Department of Health has rolled out digital infrastructure across more than 3,500 public healthcare facilities, established a Health Patient Registration System linked to the Department of Home Affairs, and created electronic medical record systems. Registration procedures for NHI users and accreditation frameworks for healthcare providers are now being finalized.
The broader African context matters here. Rwanda's community-based health insurance system, Mutuelles de Santé, achieved over 90% population coverage by building incrementally from village cooperatives. Kenya is piloting its own universal health coverage in four counties. Ghana's National Health Insurance Scheme, launched in 2003, now covers approximately 40% of the population despite persistent funding challenges.
What distinguishes South Africa is scale and ambition. The country aims to leapfrog directly to a single-payer system that would eliminate medical aid schemes entirely, a transformation no African nation has attempted at this magnitude. The question is whether the state has the institutional capacity and political will to execute it.
, a health economist at the , told that the scheme's timeline depends entirely on available financial resources, which remain undefined. Without a clear funding model, implementation risks becoming what critics call
